Skip to content

Autologous Bone Marrow Concentration for Rotator Cuff Tear

The Effect of Autologous Bone Marrow Concentration Combined With Arthroscopy for Rotator Cuff Tear

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03792594
Enrollment
40
Registered
2019-01-03
Start date
2017-05-12
Completion date
2020-12-31
Last updated
2020-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Marrow, Rotator Cuff Tear

Keywords

Bone Marrow, Mesenchymal Stromal Cells, Rotator Cuff Tear

Brief summary

This study aims to evaluate the effect of bone marrow concentration on healing of rotator cuff tear by comparing clinical and imaging outcomes between patients receiving arthroscopic repair with intraoperative bone marrow concentration and those receiving arthroscopic repair only.

Detailed description

Rotator cuff tear is a common cause of pain and disability among adults. Most tears are largely caused by the normal wear and tear that goes along with aging. Although nonsurgical treatment relieves pain and improves function in the shoulder, surgical repair for a torn rotator cuff is indicated if symptoms persisted or deteriorated after 3 months nonsurgical treatments, Recently, arthroscopic repair has become the mainstream of surgical repair for rotator cuff tear. However, the healing of a repaired tendon is not always predictable. Mesenchymal stem cells (MSCs) are pluripotent cells that can differentiate into multiple mesenchymal tissues, including tenocytes, chondrocytes and osteoblasts, as well as being a source of multiple growth factors to establish an environment conducive to soft and hard tissue regeneration. As bone marrow concentration has high concentration of mesenchymal stem cells, some studies have shown that autologous bone marrow concentration can improve the healing of tendon grafts in a bone tunnel. Therefore, the goal of this study was to evaluate the effect of bone marrow concentration on healing of rotator cuff.

Interventions

OTHERarthroscopic repair with bone marrow concentration

arthroscopic repair with bone marrow concentration

arthroscopic repair only

Sponsors

Aeon Biotechnology Corporation
CollaboratorINDUSTRY
Pei-Yuan Lee, MD
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* With diagnosis of rotator cuff tear * Age between 40 and 70 years

Exclusion criteria

* With prior history of shoulder surgery * With current or prior history of trauma or infection at shoulder * With current diagnosis of coagulopathy * With current or prior history of cancer * With current or prior history of hematological disease * Pregnancy * Patients who will not cooperate with one-year followup

Design outcomes

Primary

MeasureTime frameDescription
3-month postoperative shoulder function evaluated by Constant Shoulder Score3-month postoperativeShoulder function is evaluated using Constant Shoulder Score. The survey scores range from 0-100 with higher scores representing less dysfunction and better outcomes.

Secondary

MeasureTime frameDescription
12-month postoperative shoulder function evaluated by Constant Shoulder Score12-month postoperativeShoulder function is evaluated using Constant Shoulder Score. The survey scores range from 0-100 with higher scores representing less dysfunction and better outcomes.
3-month postoperative degree of healing evaluated by plain radiograph3-month postoperativeDegree of healing evaluated by plain radiograph
6-month postoperative degree of healing evaluated by plain radiograph6-month postoperativeDegree of healing evaluated by plain radiograph
6-month postoperative shoulder function evaluated by Constant Shoulder Score6-month postoperativeShoulder function is evaluated using Constant Shoulder Score. The survey scores range from 0-100 with higher scores representing less dysfunction and better outcomes.
6-month postoperative degree of healing evaluated by MRI6-month postoperativeDegree of healing evaluated by MRI
12-month postoperative degree of healing evaluated by MRI12-month postoperativeDegree of healing evaluated by MRI
12-month postoperative degree of healing evaluated by plain radiograph12-month postoperativeDegree of healing evaluated by plain radiograph

Countries

Taiwan

Contacts

Primary ContactChien-Sheng Lo, MD
johnlcs@gmail.com+886-975611289
Backup ContactPei-Yuan Lee, MD

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026